However, considering the lack of significant correlation between Visfatin and clinical variables in our current study, further studies are required to establish whether Visfatin plays a role in ARDS regardless of aetiology, or whether it plays an important role specifically in COVID-19. This evidence concerns the gene NAMPT and acute respiratory distress syndrome.